Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

COSCIENS Biopharma (CSCI)announced initiation of its Phase 2a clinical efficacy study of its flagship avenanthramides product being developed ...

Magna International Inc. closed 32.5% below its 52-week high of C$75.93, which the company reached on March 22nd.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Waylands dealer group boss John O’Hanlon today provided a fascinating insight into the way he assembled his portfolio of car ...

The Tampa Bay Rays have officially decided on their 2026 stadium plans. Rays owner Stuart Sternberg issued a statement ...

Jobs at risk unless demand for electric vehicles is raised, industry body warns Failing to boost demand for electric vehicles ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC) ...

According to the latest study from BCC Research, "Technical Textiles: Global Markets," is expected to grow from $213.8 billion in 2024 to $284.0 billion by the end of 2029, at a compound annual growth ...